Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Delivering genes to the heart—right where it counts!

Nature Medicine volume 5, pages 141–142 (1999)Cite this article

Abstract

In utero gene therapy to block fibronectin synthesis prevents closure of the ductus arteriosus in fetal lambs and may be a useful approach to treating certain congenital heart defects (pages 176–182).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nabel, E.G. & Leiden, J.M. Gene transfer approaches for cardiovascular disease. In Molecular Basis of Cardiovascular Disease (ed Chien, K.R.), pp. 86–112 (W.B. Saunders, Philadelphia, 1998).

    Google Scholar 

  2. Mason, C.A. et al. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin–dependent neointimal formation. Nature Med. 5, 176– 182 (1999).

    Article  CAS  Google Scholar 

  3. Lewis, A.B., Freed, M.D., Heymann, M.A., Roehl, S.L. & Kensey, R.C. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64, 893–898 ( 1981).

    Article  CAS  Google Scholar 

  4. Boudreau, N., Turley, E. & Rabinovitch, M. Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev. Biol. 143, 235–247 (1991).

    Article  CAS  Google Scholar 

  5. Boudreau, N., Clausell, N., Boyle, J. & Rabinovitch, M. Transforming growth factor–beta regulates increased ductus arteriosus endothelial glycosaminoglycan synthesis and a post–transcriptional mechanism controls increased smooth muscle fibronectin, features associated with intimal proliferation. Lab. Invest. 67, 350–359 (1992).

    CAS  PubMed  Google Scholar 

  6. Stefansson, S. & Lawrence, D.A. The serpin PAI–1 inhibits cell migration by blocking integrin αVβ3 binding to vitronectin. Nature 383, 441–443 (1996).

    Article  CAS  Google Scholar 

  7. George, E.L., Georges–Labouesse, E.N., Patel–King, R.S., Rayburn, H. & Hynes, R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079– 1091 (1993).

    CAS  Google Scholar 

  8. Barinaga, M. Tracking down mutations that can stop the heart. Science 281, 32–34 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Depts of Internal Medicine and Physiology Cardiovascular Reserch Center, University of Michigan, Ann Arbor, 48109–0644, Michigan, USA

    Elizabeth G. Nabel

Authors
  1. Elizabeth G. Nabel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nabel, E. Delivering genes to the heart—right where it counts!. Nat Med 5, 141–142 (1999). https://doi.org/10.1038/5500

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/5500

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing